Meeting
2012 Markers in Cancer
Targeted deep sequencing as a diagnostic and research method for detecting EGFR and ALK pathway driver genes in FFPE tissue of lung and colorectal carcinomas.
Authors
Sakari Knuutila
Department of Pathology, Haartman Institute and HU
Sakari Knuutila , Katja Merkkiniemi , Mikko Rönty , Aino Wirtanen , Satu Remes , Stuart Bloor , Kaisa Salmenkivi , Aija Knuuttila , Virinder Sarhadi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Poster Discussion Session A
Track
Clinical Evaluation of Biomarkers,Imaging Biomarkers,Genetics, Genomics, Epigenetics, and Gene Expression,Immune System and Immunotherapeutic Markers
Sub Track
Bioinformatics in Biomarker Research
Citation
J Clin Oncol 30: 2012 (suppl 30; abstr 39)
Abstract #
39
Poster Bd #
A8
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Migration to next-generation sequencing and the identification of RET and ROS1 rearrangements plus PTEN and MET protein expression in tumor specimens from patients with lung adenocarcinomas: Lung Cancer Mutation Consortium (LCMC 2.0).
First Author: Mark G. Kris
Poster
2014 ASCO Annual Meeting
Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas.
First Author: Juliana Eng
Poster
2023 ASCO Annual Meeting
First results from the RETgistry: A global consortium for the study of resistance to RET inhibition in RET-altered solid tumors.
First Author: Alissa Jamie Cooper
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates